Moderna’s Cancer Vaccine Breakthrough Sends Stocks Soaring
Moderna and Merck are celebrating a major milestone after their personalized mRNA cancer treatment succeeded in a late-stage trials.
As featured on
Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells.
